Skip to main content

Peer Review reports

From: Optimal, minimax and admissible two-stage design for phase II oncology clinical trials

Original Submission
31 Jan 2019 Submitted Original manuscript
3 Jun 2019 Reviewed Reviewer Report - Qing Li
17 Feb 2020 Reviewed Reviewer Report - Adrian P. Mander
20 Apr 2020 Author responded Author comments - Fei Qin
13 May 2020 Reviewed Reviewer Report - Qing Li
Resubmission - Version 2
20 Apr 2020 Submitted Manuscript version 2
Publishing
15 May 2020 Editorially accepted
20 May 2020 Article published 10.1186/s12874-020-01017-8

You can find further information about peer review here.

Back to article page